Literature DB >> 16231392

Synthesis of N-heteroaryl retinals and their artificial bacteriorhodopsins.

Susana López1, Virginia Rodríguez, Javier Montenegro, Carlos Saá, Rosana Alvarez, Carlos Silva López, Angel R de Lera, Rosana Simón, Tzvetana Lazarova, Esteve Padrós.   

Abstract

N-Heteroaryl retinals derived from indole, 1-indolizine and 3-indolizine (10 a-c) have been synthesized after their UV/Vis red-shifted absorption properties had been predicted by time-dependent density functional theory (TD-DFT) computations. The three new analogues form artificial pigments upon recombination with bacterioopsin: indolyl retinal 10 a undergoes fast and efficient reconstitution to form a species with a UV/Vis absorbance maximum similar to that of wild-type bacteriorhodopsin, whilst the indolizinyl retinals 10 b and 10 c also reconstitute in significant proportion to give noticeably red-shifted, although unstable, pigments. Significant changes in the pK(a) values of these artificial bacteriorhodopsins are interpreted as arising from nonoptimal binding-site occupancy by the chromophore due to steric constraints.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231392     DOI: 10.1002/cbic.200500148

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

1.  Investigation of spectral and kinetic properties of polymer films based on some analogs of bacteriorhodopsin.

Authors:  Anna B Druzhko; Sergey K Pirutin
Journal:  Eur Biophys J       Date:  2019-10-23       Impact factor: 1.733

Review 2.  Rhodopsins: An Excitingly Versatile Protein Species for Research, Development and Creative Engineering.

Authors:  Willem J de Grip; Srividya Ganapathy
Journal:  Front Chem       Date:  2022-06-22       Impact factor: 5.545

3.  Probing a polar cluster in the retinal binding pocket of bacteriorhodopsin by a chemical design approach.

Authors:  Rosana Simón-Vázquez; Marta Domínguez; Víctor A Lórenz-Fonfría; Susana Alvarez; José-Luís Bourdelande; Angel R de Lera; Esteve Padrós; Alex Perálvarez-Marín
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.